YourChoice Therapeutics Completes Phase 1a Clinical Study for First Hormone-Free Male Birth Control Pill

Contributed by: Business Wire

Logo

Tags

Health

Consumer

General Health

Clinical Trials

Men

Pharmaceutical

Biotechnology

YourChoice Therapeutics, Inc.

More Like This

YourChoice Therapeutics begins first-in-human trial for male birth control pill

Gynica announces First-in-Human Clinical Trial of Novel IntraVag© Treatment for Endometriosis

Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

PR Newswire associated0

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation

PR Newswire associated0

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke